Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 820 | 8.000 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 625 | 6.630 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 186 | 5.240 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 551 | 5.120 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 533 | 3.910 |
Why?
|
| Acetabulum | 17 | 2020 | 231 | 3.220 |
Why?
|
| Reoperation | 65 | 2023 | 888 | 3.020 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 222 | 2.650 |
Why?
|
| Femur | 22 | 2019 | 381 | 2.540 |
Why?
|
| Prosthesis Design | 26 | 2022 | 492 | 2.460 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 53 | 1.880 |
Why?
|
| Knee Joint | 22 | 2022 | 740 | 1.650 |
Why?
|
| Aged | 75 | 2023 | 8595 | 1.630 |
Why?
|
| Humans | 129 | 2023 | 26260 | 1.560 |
Why?
|
| Osteolysis | 8 | 2015 | 144 | 1.500 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 362 | 1.480 |
Why?
|
| Middle Aged | 69 | 2022 | 8541 | 1.410 |
Why?
|
| Postoperative Complications | 17 | 2018 | 825 | 1.350 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3283 | 1.340 |
Why?
|
| Bone Cements | 7 | 2020 | 89 | 1.330 |
Why?
|
| Male | 79 | 2022 | 14168 | 1.310 |
Why?
|
| Joint Diseases | 6 | 2021 | 112 | 1.300 |
Why?
|
| Female | 76 | 2022 | 14520 | 1.260 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 312 | 1.260 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4594 | 1.110 |
Why?
|
| Hip Joint | 14 | 2020 | 543 | 1.050 |
Why?
|
| Radiography | 21 | 2019 | 594 | 1.000 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 26 | 0.960 |
Why?
|
| Tibia | 10 | 2021 | 244 | 0.910 |
Why?
|
| Bone Resorption | 5 | 2014 | 84 | 0.850 |
Why?
|
| Vancomycin | 3 | 2018 | 51 | 0.830 |
Why?
|
| Joint Instability | 8 | 2018 | 388 | 0.820 |
Why?
|
| Hip Dislocation | 9 | 2016 | 70 | 0.810 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3285 | 0.750 |
Why?
|
| Pelvic Bones | 3 | 2012 | 18 | 0.730 |
Why?
|
| Gentamicins | 2 | 2018 | 16 | 0.730 |
Why?
|
| Tobramycin | 2 | 2018 | 10 | 0.730 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 9 | 0.720 |
Why?
|
| Synovial Fluid | 11 | 2017 | 95 | 0.710 |
Why?
|
| Tantalum | 8 | 2018 | 26 | 0.710 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 153 | 0.680 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1722 | 0.650 |
Why?
|
| Adult | 39 | 2022 | 7516 | 0.640 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 47 | 0.610 |
Why?
|
| Incidence | 9 | 2018 | 709 | 0.610 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 7 | 0.600 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 46 | 0.600 |
Why?
|
| Population Surveillance | 2 | 2018 | 103 | 0.590 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 83 | 0.570 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 44 | 0.570 |
Why?
|
| Osseointegration | 7 | 2016 | 67 | 0.560 |
Why?
|
| Osteotomy | 8 | 2014 | 166 | 0.560 |
Why?
|
| Device Removal | 7 | 2013 | 89 | 0.550 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.520 |
Why?
|
| Bupivacaine | 1 | 2016 | 45 | 0.510 |
Why?
|
| Perioperative Care | 4 | 2017 | 43 | 0.500 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 81 | 0.490 |
Why?
|
| Risk Factors | 12 | 2019 | 2221 | 0.490 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 50 | 0.490 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 106 | 0.480 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 117 | 0.470 |
Why?
|
| Femur Head | 2 | 2006 | 67 | 0.470 |
Why?
|
| Metals | 4 | 2015 | 150 | 0.460 |
Why?
|
| Prospective Studies | 9 | 2019 | 1665 | 0.450 |
Why?
|
| Decision Trees | 2 | 2011 | 13 | 0.440 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.440 |
Why?
|
| Dexamethasone | 1 | 2013 | 33 | 0.420 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 11 | 0.420 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 38 | 0.410 |
Why?
|
| Bacteremia | 1 | 2013 | 97 | 0.410 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 361 | 0.400 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 40 | 0.400 |
Why?
|
| Algorithms | 9 | 2022 | 357 | 0.400 |
Why?
|
| Ketamine | 2 | 2022 | 25 | 0.400 |
Why?
|
| Fractures, Bone | 3 | 2013 | 71 | 0.400 |
Why?
|
| Poisoning | 1 | 2012 | 2 | 0.400 |
Why?
|
| Patient Readmission | 1 | 2013 | 127 | 0.390 |
Why?
|
| Skin Diseases | 1 | 2012 | 18 | 0.380 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 151 | 0.370 |
Why?
|
| United States | 14 | 2022 | 2043 | 0.370 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 260 | 0.360 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 314 | 0.360 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 27 | 0.350 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 629 | 0.340 |
Why?
|
| Demography | 3 | 2019 | 67 | 0.330 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.330 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 16 | 0.320 |
Why?
|
| Quality of Life | 2 | 2011 | 606 | 0.310 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 37 | 0.310 |
Why?
|
| Recovery of Function | 8 | 2016 | 285 | 0.300 |
Why?
|
| Rheumatology | 3 | 2017 | 45 | 0.300 |
Why?
|
| Bone Transplantation | 4 | 2012 | 201 | 0.290 |
Why?
|
| Time Factors | 10 | 2020 | 1347 | 0.290 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 186 | 0.290 |
Why?
|
| Patient Discharge | 1 | 2009 | 152 | 0.290 |
Why?
|
| Surgeons | 4 | 2022 | 84 | 0.280 |
Why?
|
| Arthroplasty | 3 | 2022 | 146 | 0.270 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 54 | 0.270 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 92 | 0.240 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.240 |
Why?
|
| Cementation | 1 | 2005 | 33 | 0.240 |
Why?
|
| Occupational Diseases | 1 | 2005 | 21 | 0.240 |
Why?
|
| Risk Assessment | 8 | 2018 | 592 | 0.230 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 106 | 0.230 |
Why?
|
| Physical Examination | 4 | 2019 | 110 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2018 | 199 | 0.220 |
Why?
|
| Debridement | 3 | 2013 | 100 | 0.220 |
Why?
|
| Cohort Studies | 7 | 2020 | 1801 | 0.210 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 2 | 0.210 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 44 | 0.210 |
Why?
|
| Pain Measurement | 4 | 2016 | 418 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2019 | 227 | 0.210 |
Why?
|
| Preoperative Care | 5 | 2016 | 120 | 0.200 |
Why?
|
| Medicare | 4 | 2013 | 113 | 0.200 |
Why?
|
| Logistic Models | 3 | 2018 | 353 | 0.200 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 34 | 0.200 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 94 | 0.200 |
Why?
|
| Foreign Bodies | 1 | 2002 | 28 | 0.190 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 10 | 0.190 |
Why?
|
| Porosity | 5 | 2017 | 60 | 0.190 |
Why?
|
| Femoral Fractures | 2 | 2019 | 33 | 0.190 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 35 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 567 | 0.190 |
Why?
|
| Postoperative Period | 3 | 2018 | 326 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 211 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 247 | 0.180 |
Why?
|
| Leukocyte Count | 7 | 2016 | 63 | 0.180 |
Why?
|
| Bone Nails | 1 | 2020 | 13 | 0.180 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 17 | 0.170 |
Why?
|
| Arthrodesis | 1 | 2020 | 35 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2017 | 58 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 9 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 65 | 0.170 |
Why?
|
| Illinois | 2 | 2018 | 223 | 0.160 |
Why?
|
| Disease Management | 3 | 2017 | 104 | 0.160 |
Why?
|
| Polyethylene | 2 | 2021 | 132 | 0.160 |
Why?
|
| Treatment Failure | 1 | 2019 | 158 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 26 | 0.160 |
Why?
|
| Physician Assistants | 1 | 2019 | 16 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 343 | 0.150 |
Why?
|
| Microspheres | 1 | 2018 | 23 | 0.150 |
Why?
|
| Creatinine | 1 | 2018 | 51 | 0.150 |
Why?
|
| Body Mass Index | 5 | 2020 | 432 | 0.150 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 43 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 692 | 0.140 |
Why?
|
| Leukocytes | 1 | 2017 | 36 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 222 | 0.140 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 21 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 107 | 0.140 |
Why?
|
| Registries | 3 | 2022 | 170 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2017 | 249 | 0.140 |
Why?
|
| Allografts | 2 | 2015 | 206 | 0.140 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 41 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 38 | 0.130 |
Why?
|
| Methicillin | 1 | 2016 | 6 | 0.130 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 300 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 11 | 0.130 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 26 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 168 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 23 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 130 | 0.130 |
Why?
|
| Nasal Cavity | 1 | 2016 | 32 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 155 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 64 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 57 | 0.130 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 90 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 121 | 0.130 |
Why?
|
| Prevalence | 3 | 2013 | 441 | 0.130 |
Why?
|
| Patella | 2 | 2015 | 72 | 0.130 |
Why?
|
| Cell Count | 1 | 2015 | 75 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 22 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 473 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 29 | 0.120 |
Why?
|
| Nerve Block | 1 | 2016 | 67 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 294 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 160 | 0.120 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 58 | 0.120 |
Why?
|
| Length of Stay | 2 | 2013 | 290 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 24 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 314 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 96 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1034 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 16 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2013 | 21 | 0.110 |
Why?
|
| Decision Making | 2 | 2006 | 211 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2013 | 19 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 31 | 0.110 |
Why?
|
| Random Allocation | 1 | 2013 | 127 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 72 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 48 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2012 | 7 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 133 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 22 | 0.100 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 12 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 138 | 0.100 |
Why?
|
| Serologic Tests | 1 | 2011 | 9 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 422 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 170 | 0.080 |
Why?
|
| Suction | 3 | 2015 | 39 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 134 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 162 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 143 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 21 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 136 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 30 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2009 | 66 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 79 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2008 | 26 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 137 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 7 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 556 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 12 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 125 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 20 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 9 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 16 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 238 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 22 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 413 | 0.070 |
Why?
|
| Chicago | 3 | 2018 | 857 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 84 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2005 | 77 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 11 | 0.070 |
Why?
|
| Joint Dislocations | 2 | 2018 | 55 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2006 | 13 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 140 | 0.070 |
Why?
|
| Neutrophils | 2 | 2017 | 89 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 30 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 8 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 853 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 30 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 107 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 8 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 41 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 70 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 96 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 173 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 112 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 315 | 0.060 |
Why?
|
| Animals | 3 | 2007 | 3551 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 90 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 112 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 180 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 290 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 208 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 131 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 39 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 1948 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 80 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 122 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 468 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 74 | 0.050 |
Why?
|
| Social Class | 1 | 2021 | 59 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 652 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 122 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 288 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 48 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 105 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 52 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 90 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 20 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 54 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 184 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 316 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 380 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 29 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 97 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1326 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 163 | 0.040 |
Why?
|
| Spondylarthritis | 1 | 2017 | 2 | 0.040 |
Why?
|
| Cost Savings | 1 | 2017 | 31 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 321 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 47 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 456 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 2172 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 144 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 21 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 51 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 112 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 13 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 42 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 58 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 81 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 58 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 30 | 0.030 |
Why?
|
| California | 1 | 2012 | 27 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 52 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 683 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 4 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 30 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 283 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 190 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 123 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 12 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 37 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 710 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 744 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 111 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 36 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 32 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1069 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 23 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 133 | 0.020 |
Why?
|
| Research | 1 | 2006 | 40 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 134 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 249 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 9 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 211 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 104 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 315 | 0.010 |
Why?
|